They further demonstrated that KLK5 inhibition in cervical cancer cells decreases radioresistance by downregulating G2/mitotic-specific cyclin-B1 (cyclin B1) expression and blocking the transition to the G2/M phase [32]. The gene discussed is KLK5; the disease is cervical carcinoma.